Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z8EJ
|
||||
Former ID |
DIB015131
|
||||
Drug Name |
KOS-1815
|
||||
Synonyms |
CRM1 and nuclear export inhibitors (cancer); KOS-1815; KOS-2385; KOS-2464; CRM1 and nuclear export inhibitors (cancer), Kosan
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Preclinical | [548298] | ||
Company |
Kosan Biosciences Inc
|
||||
Target and Pathway | |||||
Target(s) | Exportin-1 | Target Info | Inhibitor | [544432] | |
Pathway Interaction Database | Signaling events mediated by HDAC Class II | ||||
Canonical NF-kappaB pathway | |||||
Integrin-linked kinase signaling | |||||
Signaling events mediated by HDAC Class I | |||||
Role of Calcineurin-dependent NFAT signaling in lymphocytes | |||||
FoxO family signaling | |||||
Sumoylation by RanBP2 regulates transcriptional repression | |||||
Hedgehog signaling events mediated by Gli proteins | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.